Contraceptive Device; Complications
9
1
1
6
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
0.0%
0 terminated out of 9 trials
100.0%
+13.5% vs benchmark
22%
2 trials in Phase 3/4
0%
0 of 6 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 6 completed trials
Clinical Trials (9)
Improvement of Symptoms After Removal of the Essure® Contraceptive Implant
Postplacental Copper Intrauterine Device Versus Postpartum Progesterone-only Pills on Uterine Niche Formation
Tranexamic Acid to Reduce Contraceptive-related Bleeding Side Effects
Hysteroscopic Guided Versus Ultrasound Guided Extraction of Retained IUD
The Contraceptive Efficacy and Safety of an Intravaginal Acetic Acid Thermoreversible Gel on Chinese Women.
Quality of Life After Laparoscopic Removal of Essure®
Real World Effectiveness and Safety of Hysteroscopic (Essure®) Compared to Laparoscopic Sterilization
Impact of ESSURE Devices Withdrawal on the Symptomatology of Patients
Vaginal Misoprostol Before IUD Insertion in Women With Cesarean Scar